Form D · Biotechnology
Ra Medical Systems, Inc.
Fort Mill, SC · CIK 0001716621
Offering snapshot reported Apr 6, 2023 · SEC filing
- Reported sold
- $8M Offering amount: $8M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 23, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 6, 2023 | Initial | $7,999,798 | No comparison | 1 | SEC filing |
| Aug 4, 2022 | Initial | $6,216,700 | No comparison | 14 | SEC filing |
| Jul 10, 2018 | Initial | $5,340,000 | No comparison | 64 | SEC filing |
| Jun 18, 2018 | Initial | $60,193,059 | No comparison | 7 | SEC filing |
| Jun 13, 2018 | Amendment | $18,282,000 | $17,632,000vs Sep 20, 2017 | 49 | SEC filing |
| Sep 20, 2017 | Initial | $650,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $640K
- Finders' fees
- $0
- Form D file number
- 021-478092
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Ladenburg Thalmann & Co., Inc. | 505 |
Source: Form D, filed Apr 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Maurice Buchbinder | Director |
| Martin Burstein | Director |
| Melissa Burstein | Director, Executive |
| James Caruso | Director |
| Vicki Chester | Executive |
| Martin Colombatto | Director |
| Brian Conn | Executive |
| Kevin Gertsman | Executive |
| Richard Heymann | Director |
| Dean Irwin | Director, Executive |
| Andrew Jackson | Executive |
| David A. Jenkins | Director, Executive |
| Jeffrey Kraws | Executive |
| James B. Laudenslager | Executive |
| Jonathan Will Mc Guire | Executive, Promoter |
| Will Mc Guire | Director, Executive |
| J. Kevin Mc Voy | Executive |
| Richard Mejia, Jr. | Director |
| Susanne Meline | Director |
| Steven Passey | Executive |
| William L. Schmidt | Executive |
| Joan Stafslien | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1670 Highway 160 West Suite 205
Fort Mill, SC, 29708
Fort Mill, SC, 29708